Han SS - Search Results

1

Software Application Profile: dynamicLM-a tool for performing dynamic risk prediction using a landmark supermodel for survival data under competing risks.

Fries AH, Choi E, Wu JT, Lee JH, Ding VY, Huang RJ, Liang SY, Wakelee HA, Wilkens LR, Cheng I, Han SS. Fries AH, et al. Among authors: han ss. Int J Epidemiol. 2023 Dec 25;52(6):1984-1989. doi: 10.1093/ije/dyad122. Int J Epidemiol. 2023. PMID: 37670428 Free PMC article.

2

Risk Stratification for Second Primary Lung Cancer.

Han SS, Rivera GA, Tammemägi MC, Plevritis SK, Gomez SL, Cheng I, Wakelee HA. Han SS, et al. J Clin Oncol. 2017 Sep 1;35(25):2893-2899. doi: 10.1200/JCO.2017.72.4203. Epub 2017 Jun 23. J Clin Oncol. 2017. PMID: 28644772 Free PMC article.

3

Impact of CyberKnife Radiosurgery on Overall Survival and Various Parameters of Patients with 1-3 versus ≥ 4 Brain Metastases.

Murovic J, Ding V, Han SS, Adler JR, Chang SD. Murovic J, et al. Among authors: han ss. Cureus. 2017 Oct 24;9(10):e1798. doi: 10.7759/cureus.1798. Cureus. 2017. PMID: 29282442 Free PMC article.

4

Impact of CyberKnife Radiosurgery on Median Overall Survival of Various Parameters in Patients with 1-12 Brain Metastases.

Murovic J, Ding V, Han SS, Adler JR, Chang SD. Murovic J, et al. Among authors: han ss. Cureus. 2017 Dec 8;9(12):e1926. doi: 10.7759/cureus.1926. Cureus. 2017. PMID: 29464135 Free PMC article.

5

Caution Needed for Analyzing the Risks of Second Cancers.

Han SS, Plevritis SK, Wakelee HA. Han SS, et al. J Thorac Oncol. 2018 Sep;13(9):e172-e173. doi: 10.1016/j.jtho.2018.04.018. J Thorac Oncol. 2018. PMID: 30166015 Free PMC article. No abstract available.

6

Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung Cancer.

Myall NJ, Henry S, Wood D, Neal JW, Han SS, Padda SK, Wakelee HA. Myall NJ, et al. Among authors: han ss. Clin Lung Cancer. 2019 Mar;20(2):e208-e217. doi: 10.1016/j.cllc.2018.10.003. Epub 2018 Oct 23. Clin Lung Cancer. 2019. PMID: 30442523 Free PMC article.

7

Functional Outcomes After Revascularization Procedures in Patients With Hemorrhagic Moyamoya Disease.

Abhinav K, Furtado SV, Nielsen TH, Iyer A, Gooderham PA, Teo M, Lee J, Han SS, Steinberg GK. Abhinav K, et al. Among authors: han ss. Neurosurgery. 2020 Feb 1;86(2):257-265. doi: 10.1093/neuros/nyz074. Neurosurgery. 2020. PMID: 30989221

8

Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes.

Aredo JV, Padda SK, Kunder CA, Han SS, Neal JW, Shrager JB, Wakelee HA. Aredo JV, et al. Among authors: han ss. Lung Cancer. 2019 Jul;133:144-150. doi: 10.1016/j.lungcan.2019.05.015. Epub 2019 May 15. Lung Cancer. 2019. PMID: 31200821 Free PMC article.

9

Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes".

Aredo JV, Padda SK, Kunder CA, Han SS, Neal JW, Shrager JB, Wakelee HA. Aredo JV, et al. Among authors: han ss. Lung Cancer. 2019 Nov;137:159-160. doi: 10.1016/j.lungcan.2019.08.020. Epub 2019 Aug 26. Lung Cancer. 2019. PMID: 31492438 No abstract available.

10

Predictors of visual functional outcome following treatment for cavernous sinus meningioma.

Fatima N, Ding VY, Han SS, Chang SD, Meola A. Fatima N, et al. Among authors: han ss. J Neurosurg. 2020 May 15;134(5):1435-1446. doi: 10.3171/2020.2.JNS193009. Print 2021 May 1. J Neurosurg. 2020. PMID: 32413851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,353 results

Search Page

Filters